Pediatrix Medical (MD) Equity Income (2014 - 2026)

Pediatrix Medical has disclosed Equity Income across 13 years of filings, most recently posting $692000.0 for Q1 2026.

• In Q1 2026, Equity Income rose 70.44% year-over-year to $692000.0; the TTM figure through Mar 2026 stood at $3.9 million (up 75.58% YoY), while the FY2025 annual figure was $3.6 million, up 54.99% from the prior year.
• Equity Income slipped to $692000.0 in Q1 2026, from $843000.0 in the prior quarter.
• Over the last five years, Equity Income for MD reached as high as $1.9 million in Q3 2025 and fell as low as $371000.0 in Q3 2022.
• The 5-year median for Equity Income is $490000.0 (2023), against an average of $614588.2.
• Annual changes were most pronounced in 2024 — Equity Income sank 32.68% — and 2025, when it surged 322.25%.
• A 5-year view of Equity Income shows it stood at $403000.0 in 2022, then gained by 18.86% to $479000.0 in 2023, then soared by 91.44% to $917000.0 in 2024, then fell by 8.07% to $843000.0 in 2025, then retreated by 17.91% to $692000.0 in 2026.
• According to Business Quant data, Equity Income over the past three periods registered $692000.0, $843000.0, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.